University of Cincinnati researchers working on pancreatic cancer antibody

Smoking, vaping and chewing tobacco are all officially out at the University of Cincinnati as of May 1, 2017, when a 2016 board of trustees ruling about the use and sale of tobacco took effect. STAFF FILE PHOTO

Smoking, vaping and chewing tobacco are all officially out at the University of Cincinnati as of May 1, 2017, when a 2016 board of trustees ruling about the use and sale of tobacco took effect. STAFF FILE PHOTO

CINCINNATI – University of Cincinnati researchers are working on a way to stop the growth of pancreatic cancer, according to our news partner WCPO.
UC College of Medicine researcher Vladimir Bogdanov will use a $300,000 grant from the Pancreatic Cancer Action Network to continue his research to develop an antibody that reduces the growth of pancreatic tumor cells.

WCPO reported Bogdanov said tumor cells often hijack vascular networks to fuel their own growth, and his RabMab1antibody targets a protein that promotes the growth of those networks.